Penicillium marneffei infection: an emerging disease in mainland China

Yongxuan Hu1, Junmin Zhang, Xiqing Li

  • 1Department of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 107 West Yanjiang Rd, Guangzhou, 510120, China.

Mycopathologia
|September 18, 2012
PubMed

Insights

Penicillium marneffei causes a life-threatening fungal infection, particularly in AIDS patients in Southeast Asia. Early antifungal therapy significantly reduces mortality for this emerging public health concern.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Public Health

Background:

  • Penicillium marneffei is an emerging pathogen causing systemic mycosis, especially in immunocompromised individuals like those with AIDS.
  • The incidence of penicilliosis marneffei is rapidly increasing in mainland China due to the prevalence of HIV/AIDS.
  • The infection is endemic in Southeast Asia, with a notable rise in reported cases in China.

Purpose of the Study:

  • To analyze the epidemiological and clinical features of penicilliosis marneffei in mainland China.
  • To evaluate treatment responses and prognosis of patients with P. marneffei infection.
  • To highlight the public health importance of P. marneffei as an emerging fungal pathogen.

Main Methods:

  • A comprehensive review of 668 cases of penicilliosis marneffei in mainland China from 1984 to 2009.
  • Data sources included cnki, cqvip, CBMdisc, and PubMed databases.
  • Analysis encompassed epidemiological data, clinical manifestations, laboratory findings, therapy, and outcomes.

Main Results:

  • 99.4% of cases were reported in southern China, primarily Guangxi (42.8%) and Guangdong (40.6%).
  • 87.7% of patients were co-infected with human immunodeficiency virus (HIV).
  • Common symptoms included fever, weight loss, anemia, lymphadenopathy, hepatosplenomegaly, respiratory signs, and skin lesions. Mortality was 24.3% with antifungal therapy versus 50.6% without.

Conclusions:

  • Penicillium marneffei is a significant emerging fungal pathogen in mainland China, posing a major medical and public health challenge.
  • Immunocompromised individuals in endemic areas require heightened awareness and prompt diagnosis of P. marneffei infections.
  • Antifungal therapy is crucial for improving survival rates in patients with penicilliosis marneffei.

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...